ST 1535
Cat. No.：YN322534
| 产品名称: | ST 1535 |
| CAS No.: | 496955-42-1 |
| Chemical Name: | 2-butyl-9-methyl-8-(2H-1,2,3-triazol-2-yl)-9H-purin-6-amine |
| Synonyms: | ST 1535;ST1535 |
| 分子量: | 272.3 |
| 分子式: | C12H16N8 |
| SMILES: | CCCCC1=NC(N)=C2C(N(C)C(N3N=CC=N3)=N2)=N1 |
| 存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
| 运输: | Room temperature in continental US; may vary elsewhere. |
| 产品描述: | ST 1535 是一种有效的口服活性A2A 腺苷受体拮抗剂。ST 1535 具有抗帕金森病活性和抗震颤作用。ST 1535 具有帕金森病研究的潜力。 |
| IC50和靶点: | |
| In Vitro: | |
| In Vivo: | |
| Clinical Trial: | |
| Solvent & Solubility: |
Stasi, M.A., Borsini, F., Varani, K., et al.ST 1535: a preferential A2A adenosine receptor antagonistInt. J. Neuropsychopharmacol.9(5),575-584(2006)
Tronci, E., Simola, N., Borsini, F., et al.Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in ratsEur. J. Pharmacol.566(1-3),94-102(2007)
Rose, S., Jackson, M.J., Smith, L.A., et al.The novel adenosine A2a receptor antagonist ST1535 potentiates the effects of a threshold dose of L-DOPA in MPTP treated common marmosetsEur. J. Pharmacol.546(1-3),82-87(2006)
